Lake Street Capital Issues Pessimistic Forecast for Bioceres Crop Solutions (NASDAQ:BIOX) Stock Price

Bioceres Crop Solutions (NASDAQ:BIOX) had its price objective decreased by equities researchers at Lake Street Capital from $13.00 to $8.00 in a report issued on Friday,Benzinga reports. The firm presently has a “buy” rating on the stock. Lake Street Capital’s price objective would suggest a potential upside of 44.14% from the stock’s current price.

Other analysts have also recently issued research reports about the company. Oppenheimer reduced their price objective on Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating for the company in a research report on Tuesday, January 28th. Canaccord Genuity Group reduced their price target on Bioceres Crop Solutions from $9.50 to $7.00 and set a “buy” rating for the company in a report on Friday. Four analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, Bioceres Crop Solutions currently has an average rating of “Buy” and an average target price of $10.00.

Bioceres Crop Solutions Stock Down 0.5 %

Shares of BIOX traded down $0.03 during trading hours on Friday, reaching $5.55. The company’s stock had a trading volume of 674,980 shares, compared to its average volume of 239,543. The company has a 50 day moving average of $6.65 and a two-hundred day moving average of $7.86. The company has a quick ratio of 0.87, a current ratio of 1.27 and a debt-to-equity ratio of 0.37. The firm has a market cap of $348.04 million, a price-to-earnings ratio of 277.64 and a beta of 0.57. Bioceres Crop Solutions has a 1-year low of $5.50 and a 1-year high of $14.05.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings data on Monday, November 11th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.11). The company had revenue of $92.60 million during the quarter, compared to analyst estimates of $117.15 million. Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. During the same quarter in the prior year, the company posted ($0.07) EPS. As a group, research analysts predict that Bioceres Crop Solutions will post 0.12 EPS for the current fiscal year.

Hedge Funds Weigh In On Bioceres Crop Solutions

Several hedge funds have recently bought and sold shares of BIOX. Fourth Sail Capital LP boosted its stake in shares of Bioceres Crop Solutions by 16.6% during the 4th quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company’s stock worth $22,490,000 after acquiring an additional 527,859 shares in the last quarter. Ping Capital Management Inc. lifted its holdings in Bioceres Crop Solutions by 7.3% in the 4th quarter. Ping Capital Management Inc. now owns 44,000 shares of the company’s stock worth $268,000 after purchasing an additional 3,000 shares during the last quarter. JPMorgan Chase & Co. boosted its position in Bioceres Crop Solutions by 49.3% during the third quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock worth $708,000 after purchasing an additional 29,693 shares during the period. Stifel Financial Corp grew its holdings in Bioceres Crop Solutions by 33.4% during the third quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock valued at $321,000 after purchasing an additional 10,224 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in shares of Bioceres Crop Solutions by 9.5% in the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock valued at $688,000 after purchasing an additional 5,341 shares during the period. 17.68% of the stock is owned by institutional investors and hedge funds.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.